L Corea

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine*

L Corea, Ondina Cardoni, Roberto Fogari et al. · Clinical Pharmacology & Therapeutics · 1996 · 135 citations

C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction

Stefano Tommasi, Erberto Carluccio, Maurizio Bentivoglio et al. · The American Journal of Cardiology · 1999 · 105 citations

Inflammation, Thrombosis, Uncomplicated Myocardial Infarction +9

Antihypertensive and Humoral Effects of Verapamil and Nifedipine in Essential Hypertension

G Muiesan, Enrico Agabiti‐Rosei, Maurizio Castellano et al. · Journal of Cardiovascular Pharmacology · 1982 · 88 citations

Hypertension, Cardiovascular Disease, Sodium Homeostasis +14

Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy

Erberto Carluccio, Stefano Tommasi, Maurizio Bentivoglio et al. · The American Journal of Cardiology · 2000 · 66 citations

Thrombosis, Cardiogenic Shock, Cardiovascular Disease +12

Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment.

L Corea, Marina Bentivoglio, Paolo Verdecchia · Hypertension · 1983 · 55 citations · Full text

Hypertension, Heart Failure, Atenolol Treatment +17